Hi Key Sole, a lot of research to be done on IHL and BOD imo.
Sud is our CMO, and co founder and CEO of Cannvalate which is Australias largest MM distributor. Cannvalate is distributing for AGH and MXC too, AGH being aus largest oils seller.
A while back, Cannvalate teamed up with IHL to bring the 4 trials to create novel IP for IHL. Incannex was born in addition to this as Sud joined IHL BOD as well.
Clinical Trials are very expensive and IHL didnt have the $$ to do them, so Cannvalate has capped IHL contributon to 80K per trial plus GST.
In exchange is the Cannvalate oppie package. Oppies given to cannvalate in exchange for completing trial milestones, ranging from 2-14c. This deal was done when IHL SP was around 2c. Every consecutive set gives more oppies, increasing in strike price too. They are worth 10.5M in adding cash flow to the bank, in exchange for Cannvalate to become #1 shareholder in IHL.
This last package was the last ITM package, from here on out the others are from 6-14c strike and expire Dec 2020. Further details you can research yourself, theres a lot going on here. But the way the Cannvalate oppie deal was structured indicates IHL BOD thinks SP will be 14c+ by EOY, if not Cannvalate just played themselves and wouldve got a bad deal.
Catalysts make it so if all goes well then 14c SP should easily be achievable, if not more. Sud himself has 20c oppie package with catalyst of IHL SP being 20c or over for 5 trading days minimum, expires 2021.
Happy Researching!
Add to My Watchlist
What is My Watchlist?